Literature DB >> 32715314

Use of Electronic Cigarettes to Aid Long-Term Smoking Cessation in the United States: Prospective Evidence From the PATH Cohort Study.

Ruifeng Chen, John P Pierce, Eric C Leas, Martha M White, Sheila Kealey, David R Strong, Dennis R Trinidad, Tarik Benmarhnia, Karen Messer.   

Abstract

Electronic cigarettes (e-cigarettes) are the preferred smoking-cessation aid in the United States; however, there is little evidence regarding long-term effectiveness among those who use them. We used the Population Assessment of Tobacco and Health Study to compare long-term abstinence between matched US smokers who tried to quit with and without use of e-cigarettes as a cessation aid. We identified a nationally representative cohort of 2,535 adult US smokers in 2014-2015 (baseline assessment), who, in 2015-2016 (exposure assessment), reported a past-year attempt to quit and the cessation aids used, and reported smoking status in 2016-2017 (outcome assessment; self-reported ≥12 months continuous abstinence). We used propensity-score methods to match each e-cigarette user with similar nonusers. Among US smokers who used e-cigarettes to help quit, 12.9% (95% confidence interval (CI): 9.1%, 16.7%) successfully attained long-term abstinence. However, there was no difference compared with matched non-e-cigarette users (cigarette abstinence difference: 2%; 95% CI: -3%, 7%). Furthermore, fewer e-cigarette users were abstinent from nicotine products in the long term (nicotine abstinence difference: -4%; 95% CI: -7%, -1%); approximately two-thirds of e-cigarette users who successfully quit smoking continued to use e-cigarettes. These results suggest e-cigarettes may not be an effective cessation aid for adult smokers and, instead, may contribute to continuing nicotine dependence.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Entities:  

Keywords:  e-cigarettes; long-term effectiveness; matching; nationally representative cohort; nicotine abstinence; propensity-score methods; smoking cessation

Mesh:

Year:  2020        PMID: 32715314      PMCID: PMC7705599          DOI: 10.1093/aje/kwaa161

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  27 in total

1.  Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications.

Authors:  Ron Borland; Timea R Partos; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2012-02-07       Impact factor: 4.244

2.  Large, Sparse Optimal Matching with Refined Covariate Balance in an Observational Study of the Health Outcomes Produced by New Surgeons.

Authors:  Samuel D Pimentel; Rachel R Kelz; Jeffrey H Silber; Paul R Rosenbaum
Journal:  J Am Stat Assoc       Date:  2015-04-03       Impact factor: 5.033

3.  Associations of Cigarettes Smoked Per Day with Biomarkers of Exposure Among U.S. Adult Cigarette Smokers in the Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Brian L Rostron; Catherine G Corey; Joanne T Chang; Dana M van Bemmel; Mollie E Miller; Cindy M Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-25       Impact factor: 4.254

4.  Duration of smoking abstinence and success in quitting.

Authors:  E A Gilpin; J P Pierce; A J Farkas
Journal:  J Natl Cancer Inst       Date:  1997-04-16       Impact factor: 13.506

5.  A Source of Bias in Studies of E-Cigarettes and Smoking Cessation.

Authors:  John P Pierce; Karen Messer; Eric C Leas; Sheila Kealey; Martha M White; Tarik Benmarhnia
Journal:  Nicotine Tob Res       Date:  2020-04-21       Impact factor: 4.244

6.  Real-World Effectiveness of Smoking Cessation Strategies for Young and Older Adults: Findings From a Nationally Representative Cohort.

Authors:  Shannon Lea Watkins; Johannes Thrul; Wendy Max; Pamela M Ling
Journal:  Nicotine Tob Res       Date:  2020-08-24       Impact factor: 4.244

7.  Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives.

Authors:  David B Abrams; Allison M Glasser; Jennifer L Pearson; Andrea C Villanti; Lauren K Collins; Raymond S Niaura
Journal:  Annu Rev Public Health       Date:  2018-01-11       Impact factor: 21.981

8.  Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton
Journal:  Tob Control       Date:  2016-08-08       Impact factor: 7.552

9.  E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation.

Authors:  Kenneth E Warner; David Mendez
Journal:  Nicotine Tob Res       Date:  2019-01-01       Impact factor: 4.244

10.  Effectiveness of Pharmaceutical Smoking Cessation Aids in a Nationally Representative Cohort of American Smokers.

Authors:  Eric C Leas; John P Pierce; Tarik Benmarhnia; Martha M White; Madison L Noble; Dennis R Trinidad; David R Strong
Journal:  J Natl Cancer Inst       Date:  2018-06-01       Impact factor: 13.506

View more
  8 in total

1.  Investigating the effect of e-cigarette use on quitting smoking in adults aged 25 years or more using the PATH study.

Authors:  Peter N Lee; John S Fry
Journal:  F1000Res       Date:  2020-09-07

2.  Switching stories: user testimonials on juul.com continue to contradict JUUL's switch ≠ cessation narrative.

Authors:  Joanne G Patterson; Devin T LaPolt; Alexis R Miranda; Patricia J Zettler; Micah Berman; Megan E Roberts; Brittney Keller-Hamilton; Amy K Ferketich
Journal:  Tob Control       Date:  2020-11-05       Impact factor: 7.552

Review 3.  How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review.

Authors:  Maciej L Goniewicz; Connor R Miller; Edward Sutanto; Dongmei Li
Journal:  Harm Reduct J       Date:  2020-11-23

4.  Incidence of Cigarette Smoking Relapse Among Individuals Who Switched to e-Cigarettes or Other Tobacco Products.

Authors:  John P Pierce; Ruifeng Chen; Sheila Kealey; Eric C Leas; Martha M White; Matthew D Stone; Sara B McMenamin; Dennis R Trinidad; David R Strong; Tarik Benmarhnia; Karen Messer
Journal:  JAMA Netw Open       Date:  2021-10-01

Review 5.  Chemosensory Contributions of E-Cigarette Additives on Nicotine Use.

Authors:  Natalie L Johnson; Theresa Patten; Minghong Ma; Mariella De Biasi; Daniel W Wesson
Journal:  Front Neurosci       Date:  2022-07-19       Impact factor: 5.152

6.  Understanding the role of e-cigarette use in smoking cessation based on the stages of change model.

Authors:  Wonjeong Yoon; Inhyung Cho; Sung-Il Cho
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

7.  Association between observing peers vaping on campus and E-cigarette use and susceptibility in middle and high school students.

Authors:  Dale S Mantey; Onyinye Omega-Njemnobi; Felisa A Ruiz; Tara L Vaughn; Steven H Kelder; Andrew E Springer
Journal:  Drug Alcohol Depend       Date:  2020-12-24       Impact factor: 4.492

8.  A Population-Level Assessment of Smoking Cessation following a Diagnosis of Tobacco- or Nontobacco-Related Cancer among United States Adults.

Authors:  Richard S Matulewicz; Marc A Bjurlin; Zachary Feuer; Danil V Makarov; Scott E Sherman; Joy Scheidell; Maria R Khan; Omar El-Shahawy
Journal:  J Smok Cessat       Date:  2021-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.